
June 23 (Reuters) - Carisma Therapeutics Inc CARM.O:
CARISMA THERAPEUTICS AND ORTHOCELLIX ENTER INTO DEFINITIVE MERGER AGREEMENT TO CREATE COMPANY FOCUSED ON REGENERATIVE CELL THERAPIES FOR ORTHOPEDIC DISEASES
CARISMA THERAPEUTICS INC - ORTHOCELLIX TO MERGE INTO WHOLLY-OWNED SUBSIDIARY OF CARISMA
CARISMA THERAPEUTICS INC - ORTHOCELLIX STOCKHOLDER TO OWN 90% OF COMBINED COMPANY POST-MERGER
CARISMA THERAPEUTICS INC - TO BE RENAMED ORTHOCELLIX AND TRADE UNDER TICKER OCLX
CARISMA THERAPEUTICS: TO ISSUE TO PRE-MERGER ORTHOCELLIX STOCKHOLDER SHARES OF CO'S COMMON STOCK AS MERGER CONSIDERATION